[Bronchopulmonary Kaposi's disease in 2 AIDS patients living in a zone of high tuberculosis/HIV prevalence]

Rev Pneumol Clin. 2002 Jun;58(3 Pt 1):163-7.
[Article in French]

Abstract

The epidemic form of Kaposi's disease, called Kaposi-AIDS, was first described in 1981 by Hymmes in two young AIDS patients. Lung lesions are observed in 10 to 45% of patients with cutaneous Kaposi and are the second leading localization of visceral involvement after the digestive tract. Diagnosis and management of these visceral forms remains difficult. We report two cases of broncho-pulmonary Kaposi-AIDS in two patients treated for cutaneous Kaposi's disease. The diagnosis was made on the basis of epidemiological, clinical, biological, radiological, endoscopic, and histological evidence. The diagnosis was achieved by elimination after ruling out all other opportunistic diseases with pulmonary tropism. The fear of miliary tuberculosis remains strong in zones with a high prevalence of tuberculosis. Despite considerable improvement with antiretroviral drugs, especially antiproteases, outcome remains unpredictable with or without specific treatment.

Publication types

  • Case Reports

MeSH terms

  • Acquired Immunodeficiency Syndrome / complications*
  • Adult
  • Anti-HIV Agents / therapeutic use
  • Biopsy
  • Bronchoscopy
  • Diagnosis, Differential
  • Female
  • Follow-Up Studies
  • Humans
  • Lung / pathology
  • Lung Diseases / complications*
  • Lung Diseases / diagnosis
  • Lung Diseases / diagnostic imaging
  • Lung Diseases / drug therapy
  • Lung Diseases / pathology
  • Male
  • Protease Inhibitors / therapeutic use
  • Radiography, Thoracic
  • Skin / pathology
  • Skin Diseases / complications*
  • Skin Diseases / diagnosis
  • Skin Diseases / pathology
  • Time Factors
  • Xeroderma Pigmentosum / complications*
  • Xeroderma Pigmentosum / diagnosis
  • Xeroderma Pigmentosum / diagnostic imaging
  • Xeroderma Pigmentosum / drug therapy
  • Xeroderma Pigmentosum / pathology

Substances

  • Anti-HIV Agents
  • Protease Inhibitors